The American economy is experiencing a crisis in long-term unemployment that has enormous human and economic costs.

Successfully translating scientific discoveries requires a sense of urgency, which some disease foundations seem to have, and many big pharmas appear to need. Patients waiting expectantly for medical research to produce important new cures are finding bad news almost everywhere they turn.

New data show that health spending over the past several years has been normalizing toward the rate of general inflation, rather than growing higher and higher, as had been the case almost continuously since the 1970s.

The health news for the New York City is good — very good, in fact. And it must be especially gratifying to Bloomberg, given his longstanding personal commitment to public health. But it isn’t clear that the official narrative of New York’s health progress actually conforms with the health story for New York over the last decade.

A surprising new study on heart disease treatments will not just change medicine--it will help shape basic science.

A poignant story in Thursday’s Boston Globe describes how the O’Donnell family of Boston channeled their love of a son, Joey, who died tragically at the age of 12 from cystic fibrosis, into a successful mission to develop impactful new treatments for this terrible affliction.

Will consumer-oriented health companies make doctors obsolete?